- Home
- SEG vs CADL Comparison
SEG vs CADL Comparison
Compare SEG & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEG
- CADL
- Stock Information
- Founded
- SEG 2024
- CADL 1999
- Country
- SEG United States
- CADL United States
- Employees
- SEG N/A
- CADL N/A
- Industry
- SEG
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- SEG
- CADL Health Care
- Exchange
- SEG NYSE
- CADL Nasdaq
- Market Cap
- SEG 343.2M
- CADL 306.4M
- IPO Year
- SEG N/A
- CADL 2021
- Fundamental
- Price
- SEG $23.74
- CADL $11.63
- Analyst Decision
- SEG
- CADL Strong Buy
- Analyst Count
- SEG 0
- CADL 4
- Target Price
- SEG N/A
- CADL $19.75
- AVG Volume (30 Days)
- SEG 80.9K
- CADL 1.2M
- Earning Date
- SEG 03-04-2025
- CADL 03-27-2025
- Dividend Yield
- SEG N/A
- CADL N/A
- EPS Growth
- SEG N/A
- CADL N/A
- EPS
- SEG N/A
- CADL N/A
- Revenue
- SEG $111,487,000.00
- CADL N/A
- Revenue This Year
- SEG N/A
- CADL N/A
- Revenue Next Year
- SEG N/A
- CADL N/A
- P/E Ratio
- SEG N/A
- CADL N/A
- Revenue Growth
- SEG 36.09
- CADL N/A
- 52 Week Low
- SEG $22.51
- CADL $1.34
- 52 Week High
- SEG $36.50
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- SEG N/A
- CADL 72.95
- Support Level
- SEG N/A
- CADL $8.11
- Resistance Level
- SEG N/A
- CADL $13.68
- Average True Range (ATR)
- SEG 0.00
- CADL 0.78
- MACD
- SEG 0.00
- CADL 0.42
- Stochastic Oscillator
- SEG 0.00
- CADL 70.29
About SEG SEAPORT ENTERTAINMENT GROUP INC
Seaport Entertainment Group Inc own, operate and develop a unique collection of assets positioned at the intersection of entertainment and real estate. Its objective is to integrate one-of-a-kind real estate assets with a variety of restaurant, retail and leisure offerings to form vibrant mixed-use destinations where customers can work, play and socialize in one cohesive setting. The company has three operating segments: (1) Landlord Operations; (2) Hospitality; and (3) Sponsorships, Events, and Entertainment. Key revenue is generated from Landlord Operations which consists of the company's rental operations.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.